Gantenerumab: A novel human anti-Abeta antibody demonstrates sustained cerebral amyloid-beta binding and elicits cell-mediated removal of human amyloid-beta

Manuscript Number: 

11-0977R1

Author(s): 
Michael Bardroff, Karlheinz Baumann, Jorg Benz, Bernd Bohrmann, Francoise Gerber, Walter Huber, Frederic Knoflach, Hansruedi Loetscher, Jurg Messer, Christer Nordstedt, Krisztina Oroszlan, Robert Rauchenberger, Wolfgang F. Richter, Christine Rothe, Margit Urban, Michael Winter

Disclosures

Michael Bardroff

  • Sponsors:
    I was emloyed at MorphoSys during the conduct of the study.
    Patents/Royalties
    I am patent author on the patent US2005169925A.

Karlheinz Baumann

  • Equity:
    F.Hoffmann-La Rcohe Ltd.
    Sponsors:
    F.Hoffmann-La Rcohe Ltd.

Jorg Benz

  • Sponsors:
    Employee of F.Hoffmann-La Roche Ltd.

Bernd Bohrmann

  • Equity:
    Equity ownership/stock options
    Sponsors:
    F.Hoffmann La Roche
    Patents/Royalties
    Patent Author

Francoise Gerber

  • Equity:
    stock options
    Sponsors:
    F.Hoffmann La-Roche

Walter Huber

  • Equity:
    I'm owning stock options from F.Hoffmann-La Roche
    Sponsors:
    I'm an emplyee with Hoffmann La Roche
    Patents/Royalties
    I'm a patent author for the subject of the paper

Frederic Knoflach

  • Sponsors:
    F.Hoffmann-La Roche Ltd.

Hansruedi Loetscher

  • Equity:
    Stock options of F. Hoffmann-La Roche Ltd.
    Sponsors:
    Employee of F. Hoffmann-La Roche Ltd.
    Patents/Royalties
    Author of patents owned by F. Hoffmann-La Roche Ltd.

Jurg Messer

  • Equity:
    stock options (ROG.VX) worth CHF 240/year.
    Sponsors:
    F. Hoffmann-La Roche Ltd.

Christer Nordstedt

  • Sponsors:
    F.Hoffmann La Roche during the conduct of the study
    Patents/Royalties
    patent coauthor

Krisztina Oroszlan

  • Equity:
    Stock options
    Sponsors:
    Employed at F.Hoffmann-La Roche

Robert Rauchenberger

  • Sponsors:
    Employed at MorphoSys at present as well as during the conduct of the study

Wolfgang F. Richter

  • Equity:
    Wolfgang F. Richter holds financial interest in Roche.
    Sponsors:
    F. Hoffmann-La Roche Ltd.

Christine Rothe

  • Equity:
    shares of Morphosys
    Sponsors:
    employed at MOR during the conduct of the study
    Patents/Royalties
    patent authorship

Margit Urban

  • Equity:
    Stock options of MorphoSys AG
    Sponsors:
    Currently and at time of the study employed by MorphoSys

Michael Winter

  • Equity:
    equity owenership/stock options
    Sponsors:
    F.Hoffmann La-Roche